knowledge -WSS

knowledge

author：comprehensive 2025-09-03 09:37:13 - browse：4

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

focus

entertainment

WSS

Indictment alleges Trump's ex

Biden administration begins canceling student loan debt for 804,000 borrowers

Timeline: How the deadly wildfires took over Maui day by day

Neuroscience startup Neumora files for IPO

Psilocybin's anti

Health AI: on the border between health care and tech

entertainment

knowledge

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Senators push IRS to launch nonprofit hospital probe

How to save PrEP access — and even expand it

CDC advisory panel says seniors 'may' get RSV vaccine

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Appeals court upholds limits to abortion pill

Bright Health sells Medicare Advantage business to Molina

Illinois Supreme Court finds assault weapons ban constitutional

Medicare details structure of new drug price negotiation program

Drug firms test therapies to halt Alzheimer’s before symptoms arise

hotspot

Bird flu researchers hone in on Finland’s mink farms

Montana youths win climate lawsuit against state for promoting fossil fuels

Schizophrenia gene found to be linked to cells' energy dysfunction

Hospitals are dialing back on venture capital investing

What do new weight loss drugs mean for bariatric surgery?

Senators push IRS to launch nonprofit hospital probe

Wikipedia

focus

entertainment

hotspot